Read more http://www.eurekalert.org/pub_releases/2011-04/joci-mop041611.php
Monday, 18 April 2011 18:00
Move over Prozac: New drug offers hope for depression
The brain chemistry that underlies depression is incompletely understood, but research suggests that aberrant signaling by a chemical called Brain-Derived Neurotrophic Factor through its receptor TrkB, may contribute to anxiety and depression. Here, researchers describe a screen for stable small molecules that could specifically inhibit TrkB action. They identified one they dubbed ANA-12, which had potent behavioral effects when administered to mice that suggest it will have antidepressant and anti-anxiety activity in humans.
Read 572 times
|
Published in
Psychology News
